ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
April 09, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, April 09, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
February 27, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
February 16, 2024 09:30 ET
|
ImmuCell Corporation
PORTLAND, Maine, Feb. 16, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023
January 08, 2024 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Jan. 08, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023
November 13, 2023 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Nov. 13, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023
November 07, 2023 12:15 ET
|
ImmuCell Corporation
PORTLAND, Maine, Nov. 07, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023
October 05, 2023 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Oct. 05, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Submission of CMC Technical Section to the FDA
August 29, 2023 08:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 29, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023
August 10, 2023 16:05 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 10, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023
August 07, 2023 12:00 ET
|
ImmuCell Corporation
PORTLAND, Maine, Aug. 07, 2023 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets...